CEMEX 3Q26: EBITDA Up 12% to $990M, FCF Up 34%, 2026 EBITDA Outlook Raised to 16-17%
CX sits 16% above its 52-week low of $9.13.
Summary
CEMEX grew 3Q26 EBITDA 12% to $990 million and free cash flow from operations 34% to a record $723 million, cut net debt to $5.4 billion, and raised its 2026 EBITDA growth outlook to 16%-17%.
Key Events · Earnings and Guidance · CX
-
3Q26 EBITDA Grows 12% to $990M
Sales rose 8% to $4,590 million and Operating EBITDA rose 12% to $990 million, lifting margin 0.8pp to 21.6%; Operating EBIT grew 19% to $652 million.
-
Record 3Q Free Cash Flow of $723M
Free cash flow from operations rose 34% to $723 million in the quarter and 194% to $1,389 million year-to-date, with a trailing-twelve-month adjusted conversion rate of about 60%.
-
Net Debt Cut to $5.4B, Leverage 1.80x
Net debt fell $802 million sequentially to $5,423 million from $6,225 million at 2Q26, and the leverage ratio improved to 1.80x from 2.08x.
-
2026 EBITDA Outlook Raised to 16-17%
Management now expects a 16%-17% year-over-year EBITDA increase for 2026, with maintenance capex of about $900 million and cash taxes of about $400 million.
Analysis · CX · Manufacturing
CEMEX delivered its fifth straight quarter of double-digit EBITDA growth and its second consecutive quarter of ~60% trailing free-cash-flow conversion, while cutting net debt by $802 million sequentially to $5.4 billion and bringing leverage down to 1.80x from 2.08x. The company also raised its 2026 EBITDA growth outlook to 16%-17% year-over-year, which is the single most important line for how the market will re-rate the stock. Mexico carried the quarter (EBITDA +30% YoY, margin 37.0%), offsetting a soft US result (EBITDA -4% on an unplanned outage, raw-material inflation and lower cement prices). Asset pruning is now a real cash story: more than $200 million of estimated proceeds from completed and announced divestments, plus roughly $485 million of Colombian assets held for sale expected to close by year-end.
How filings like this one have moved
In the 30 days to Oct 26, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CX was trading at $10.56 on NYSE in the Manufacturing sector, with a market capitalization of approximately $15.5B. The 52-week trading range was $9.13 to $13.67. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.